Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification

BackgroundFor expression profiling to have a practical impact in the management of immune-related disease it is essential that it can be applied to peripheral blood cells. Early studies have used total peripheral blood mononuclear cells, and as a consequence the majority of the disease-related signatures identified have simply reflected differences in the relative abundance of individual cell types between patients and controls. To identify cell-specific changes in transcription it would be necessary to profile purified leucocyte subsets.ResultsWe have used sequential rounds of positive selection to isolate CD4 and CD8 T cells, CD19 B cells, CD14 monocytes and CD16 neutrophils for microarray analysis from a single blood sample. We compared gene expression in cells isolated in parallel using either positive or negative selection and demonstrate that there are no significant consistent changes due to positive selection, and that the far inferior results obtained by negative selection are largely due to reduced purity. Finally, we demonstrate that storing cells prior to separation leads to profound changes in expression, predominantly in cells of the myeloid lineage.ConclusionLeukocyte subsets should be prepared for microarray analysis by rapid positive selection.

[1]  A. Kuramoto,et al.  Identification of early plasma cells in peripheral blood and their clinical significance , 1996, British journal of haematology.

[2]  S. Zahler,et al.  The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. , 1997, Journal of immunological methods.

[3]  I. Manyonda,et al.  A critical evaluation of the magnetic cell sorter and its use in the positive and negative selection of CD45RO+ cells. , 1992, Journal of immunological methods.

[4]  G. Bepler,et al.  Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients , 2004, Clinical Cancer Research.

[5]  P. Gregersen,et al.  Peripheral blood gene expression profiling in rheumatoid arthritis , 2005, Genes and Immunity.

[6]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[8]  J. Gregg,et al.  Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. , 2006, Genomics.

[9]  G. Karypis,et al.  Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation , 2004, Genes and Immunity.

[10]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[11]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[12]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[14]  P. Gregersen,et al.  Microarray Analyses of Peripheral Blood Cells Identifies Unique Gene Expression Signature in Psoriatic Arthritis , 2005, Molecular medicine.

[15]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[16]  J. Gartner,et al.  Positive selection of NK1.1+ cells on a magnetic cell separator (MACS). , 1995, Journal of immunological methods.

[17]  Peter S Linsley,et al.  Individual-specific variation of gene expression in peripheral blood leukocytes. , 2004, Genomics.

[18]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[19]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[20]  Nir Friedman,et al.  Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity , 2004, Annals of neurology.

[21]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[22]  R. Djukanović,et al.  Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS). , 1996, Journal of immunological methods.

[23]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[24]  V. P. Collins,et al.  Global amplification of mRNA by template-switching PCR: linearity and application to microarray analysis. , 2003, Nucleic acids research.

[25]  S. Groshen,et al.  Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  Tom C. Freeman,et al.  An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes , 2006, Nucleic acids research.

[27]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[28]  L. Staudt,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[29]  D. Allen,et al.  Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS). , 1993, Cytometry.

[30]  H Korb,et al.  Magnetic activated cell sorting (MACS) — a new immunomagnetic method for megakaryocytic cell isolation: Comparison of different separation techniques , 1994, European journal of haematology.

[31]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .